Ofer Merimsky

9.8k total citations
188 papers, 2.9k citations indexed

About

Ofer Merimsky is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ofer Merimsky has authored 188 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 95 papers in Oncology and 35 papers in Surgery. Recurrent topics in Ofer Merimsky's work include Sarcoma Diagnosis and Treatment (60 papers), Vascular Tumors and Angiosarcomas (22 papers) and Lung Cancer Treatments and Mutations (18 papers). Ofer Merimsky is often cited by papers focused on Sarcoma Diagnosis and Treatment (60 papers), Vascular Tumors and Angiosarcomas (22 papers) and Lung Cancer Treatments and Mutations (18 papers). Ofer Merimsky collaborates with scholars based in Israel, United States and France. Ofer Merimsky's co-authors include Samario Chaitchik, Moshe Inbar, Yehuda Kollender, Isaac Meller, Jacob Bickels, Josephine Issakov, Ronit Sagi‐Eisenberg, Gideon Flusser, Pnina Fishman and Sivan Shamai and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Ofer Merimsky

184 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Merimsky Israel 30 1.3k 1.2k 581 482 402 188 2.9k
Sigbjørn Smeland Norway 32 1.4k 1.1× 858 0.7× 509 0.9× 637 1.3× 585 1.5× 105 2.9k
Jean‐Emmanuel Kurtz France 28 1.1k 0.9× 891 0.7× 364 0.6× 420 0.9× 525 1.3× 113 2.6k
Ilmo Kellokumpu Finland 34 784 0.6× 1.3k 1.0× 1.7k 2.9× 393 0.8× 388 1.0× 81 2.9k
Christina L. Roland United States 30 1.4k 1.1× 1.7k 1.4× 612 1.1× 945 2.0× 295 0.7× 126 3.6k
Yang Yao China 29 1.1k 0.8× 1.2k 1.0× 333 0.6× 694 1.4× 203 0.5× 125 2.4k
Luís Teixeira France 28 698 0.5× 1.1k 0.9× 362 0.6× 604 1.3× 255 0.6× 93 3.3k
Vincenzo Tombolini Italy 36 1.4k 1.1× 1.5k 1.3× 953 1.6× 1.1k 2.2× 208 0.5× 224 4.4k
Jungnam Joo South Korea 35 1.2k 0.9× 1.2k 1.0× 956 1.6× 698 1.4× 159 0.4× 188 4.0k
Takuo Hayashi Japan 30 1.4k 1.1× 967 0.8× 725 1.2× 632 1.3× 167 0.4× 211 2.9k
Francesco Facciolo Italy 34 2.2k 1.7× 812 0.7× 492 0.8× 530 1.1× 169 0.4× 158 3.6k

Countries citing papers authored by Ofer Merimsky

Since Specialization
Citations

This map shows the geographic impact of Ofer Merimsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Merimsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Merimsky more than expected).

Fields of papers citing papers by Ofer Merimsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Merimsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Merimsky. The network helps show where Ofer Merimsky may publish in the future.

Co-authorship network of co-authors of Ofer Merimsky

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Merimsky. A scholar is included among the top collaborators of Ofer Merimsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Merimsky. Ofer Merimsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutfeld, Orit, Tatiana Rabin, Leor Zach, et al.. (2024). The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancer. Surgical Oncology. 56. 102119–102119. 1 indexed citations
2.
Shamai, Sivan, Ofer Merimsky, Ido Wolf, et al.. (2023). The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab. International Journal of Cardiology. 397. 131642–131642. 6 indexed citations
3.
Siegelmann‐Danieli, Nava, et al.. (2023). Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer. Cancer. 129(18). 2789–2797. 10 indexed citations
4.
Hasson, Shira Peleg, Dov Hershkovitz, Yuval Raviv, et al.. (2022). Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers. 15(1). 218–218.
5.
Merimsky, Ofer, et al.. (2022). Radiation Therapy Before Repeat Wide Resection for Unplanned Surgery of Soft Tissue Sarcoma (“Oops” Operation) Results in Improved Disease-Free Survival. Advances in Radiation Oncology. 7(6). 101007–101007. 2 indexed citations
6.
Kushnir, Igal, et al.. (2014). Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?. Medical Oncology. 31(5). 936–936. 4 indexed citations
7.
Meller, Isaac, Avi A. Weinbroum, Jacob Bickels, et al.. (2008). Fifteen years of bone tumor cryosurgery: A single-center experience of 440 procedures and long-term follow-up. European Journal of Surgical Oncology. 34(8). 921–927. 34 indexed citations
8.
Kollender, Yehuda, et al.. (2007). Synovial sarcoma of the extremities and trunk: a long-lasting disease. Oncology Reports. 18(6). 1577–81. 6 indexed citations
9.
Neudorfer, Meira, et al.. (2006). Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: argument against screening. British Journal of Ophthalmology. 91(1). 74–75. 34 indexed citations
10.
Merimsky, Ofer, Rony Weitzen, Tamar Peretz, et al.. (2004). Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2. Annals of Oncology. 15(4). 610–612. 22 indexed citations
11.
Kollender, Yehuda, Issac Meller, Jacob Bickels, et al.. (2003). Role of adjuvant cryosurgery in intralesional treatment of sacral tumors. Cancer. 97(11). 2830–2838. 45 indexed citations
12.
Merimsky, Ofer, et al.. (2000). Choriocarcinoma Arising in a Squamous Cell Carcinoma of the Esophagus. American Journal of Clinical Oncology. 23(2). 203–206. 7 indexed citations
13.
Merimsky, Ofer, C. Lepéchoux, Philippe Terrier, et al.. (2000). Primary Sarcomas of the Central Nervous System. Oncology. 58(3). 210–214. 35 indexed citations
14.
Merimsky, Ofer. (1998). Cigarette smoking and skin cancer. Clinics in Dermatology. 16(5). 585–588. 20 indexed citations
15.
Merimsky, Ofer, Yehuda Shoenfeld, & Pnina Fishman. (1998). The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions. Clinical Reviews in Allergy & Immunology. 16(3). 227–236. 15 indexed citations
16.
Greif, Joel, et al.. (1998). Primary Liposarcoma of the Mediastinum. Sarcoma. 2(3-4). 205–207. 8 indexed citations
17.
Merimsky, Ofer, et al.. (1994). Antigens and Antibodies in Malignant Melanoma. Tumor Biology. 15(4). 188–202. 31 indexed citations
18.
Merimsky, Ofer, Irith Reider‐Groswasser, Nely Wigler, & Samario Chaitchik. (1992). Encephalopathy in ifosfamide-treated patients. Acta Neurologica Scandinavica. 86(5). 521–525. 24 indexed citations
19.
Merimsky, Ofer, et al.. (1992). Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face. Anti-Cancer Drugs. 3(5). 481–484. 19 indexed citations
20.
Merimsky, Ofer, et al.. (1990). Pregnancy and cavernous sinus involvement in a patient with primary non-Hodgkin's lymphoma of bone.. PubMed. 26(9). 520–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026